Clinical Trials Logo

Clinical Trial Summary

Incarcerated inguinal hernia is one of the common acute abdomen abdominal surgery, often prone to intestinal necrosis and acute peritonitis.Using traditional tension hernia reparation, the recurrence rate were as high as 30%. In recent years, biological materials especially acellular matrix materials (Acellular Dermal Matrix, ADM) in resisting the infection, has become a research hotspot. In the project, the investigators try to address the role of ADM in incarcerated inguinal hernia patients.


Clinical Trial Description

observation indicator:

1. recurrence rate after operation

2. incidence rate of complications

3. postoperative hospital stay

4. hospitalization costs

5. Self-evaluation of gastroesophageal reflux symptoms and quality of life(QOL) in 6th-month, 1st-year,2nd-year,3rd-year,4th-year and 5th-year after operation ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02469142
Study type Interventional
Source Xijing Hospital of Digestive Diseases
Contact
Status Active, not recruiting
Phase Phase 2/Phase 3
Start date January 2015
Completion date December 2019

See also
  Status Clinical Trial Phase
Completed NCT05251350 - Incarcerated Right Inguinal Hernia Containing Sigmoid Colon: An Unusual Case Report
Recruiting NCT02599623 - Safety and Efficacy of Local Anesthesia in Emergency Inguinal Hernia Surgery N/A
Enrolling by invitation NCT04785430 - Incarceration Risk Factors in Inguinal Hernia.